• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近期研究对小鼠自发性淋巴细胞肿瘤分类的贡献。

Contributions of recent research to the classification of spontaneous lymphoid cell neoplasms in mice.

作者信息

Pattengale P K, Frith C H

出版信息

Crit Rev Toxicol. 1986;16(3):185-212. doi: 10.3109/10408448609037464.

DOI:10.3109/10408448609037464
PMID:2420529
Abstract

The present review focuses on the mouse as an experimental immunopathologic model for non-Hodgkins' lymphomas and related leukemias. Immunomorphologic evidence will be presented which demonstrates that B and T cell subtypes of mouse lymphoid cell neoplasms resemble and are analogous to B and T cell subtypes of human lymphoid cell neoplasms. The many experimental advantages of the mouse system will be stressed with a particular emphasis on the concept that this newly defined immunomorphologic approach should be effectively combined with biologic, molecular, and cytogenetic parameters.

摘要

本综述聚焦于小鼠作为非霍奇金淋巴瘤及相关白血病的实验性免疫病理模型。将展示免疫形态学证据,其表明小鼠淋巴样细胞瘤的B细胞和T细胞亚型与人类淋巴样细胞瘤的B细胞和T细胞亚型相似且具有可比性。将着重强调小鼠系统的诸多实验优势,尤其强调这一最新定义的免疫形态学方法应与生物学、分子和细胞遗传学参数有效结合的概念。

相似文献

1
Contributions of recent research to the classification of spontaneous lymphoid cell neoplasms in mice.近期研究对小鼠自发性淋巴细胞肿瘤分类的贡献。
Crit Rev Toxicol. 1986;16(3):185-212. doi: 10.3109/10408448609037464.
2
Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.淋巴增生性疾病的实验模型。小鼠作为人类非霍奇金淋巴瘤及相关白血病的模型。
Am J Pathol. 1983 Nov;113(2):237-65.
3
Recent advances in diagnosis and classification of leukemias and lymphomas.
Dis Markers. 1990 Sep-Oct;8(5):231-64.
4
Application of cytogenetics in neoplastic diseases.细胞遗传学在肿瘤性疾病中的应用。
Crit Rev Clin Lab Sci. 1985;22(3):219-74. doi: 10.3109/10408368509165844.
5
Immunomorphologic classification of spontaneous lymphoid cell neoplasms occurring in female BALB/c mice.雌性BALB/c小鼠自发性淋巴细胞肿瘤的免疫形态学分类
J Natl Cancer Inst. 1983 Jan;70(1):169-79.
6
Chromosomal approaches to hematopoietic oncogenesis.造血肿瘤发生的染色体研究方法。
Stem Cells. 1993 Jan;11(1):9-19. doi: 10.1002/stem.5530110104.
7
The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.AML1基因:一种参与髓系和淋巴系白血病发病机制的转录因子。
Haematologica. 1997 May-Jun;82(3):364-70.
8
Lymphomas and leukemias in mice.小鼠的淋巴瘤和白血病。
Exp Toxicol Pathol. 2006 Jul;57(5-6):377-81. doi: 10.1016/j.etp.2006.01.007. Epub 2006 May 18.
9
Some questions on the significance of chromosome alterations in leukemias and lymphomas: a review.白血病和淋巴瘤中染色体改变的意义相关若干问题:综述
Am J Med Genet. 1984 Jul;18(3):471-81. doi: 10.1002/ajmg.1320180317.
10
[Chromosome aberrations and genes in human and experimental leukemias].
Rinsho Byori. 1990 May;38(5):509-13.

引用本文的文献

1
Phenotyping analysis of p53 knockout mice produced by gene editing and comparison with conventional p53 knockout mice.通过基因编辑技术构建的 p53 基因敲除小鼠表型分析及其与传统 p53 基因敲除小鼠的比较。
Genes Genomics. 2019 Jun;41(6):701-712. doi: 10.1007/s13258-019-00785-y. Epub 2019 Apr 15.
2
Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.ARF转录激活因子DMP1的破坏促进细胞永生化、Ras转化和肿瘤发生。
Genes Dev. 2000 Jul 15;14(14):1797-809.
3
The role of interleukin-6 in certain age-related diseases.
Drugs Aging. 1994 Nov;5(5):358-65. doi: 10.2165/00002512-199405050-00005.
4
Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes.人类疾病的动物模型。携带并表达活化细胞癌基因的转基因小鼠中自发肿瘤的病理学和分子生物学。
Am J Pathol. 1989 Jul;135(1):39-61.
5
Spontaneous follicular center cell lymphomas of B cell origin in cataract mice.白内障小鼠中起源于B细胞的自发性滤泡中心细胞淋巴瘤
Jpn J Cancer Res. 1992 Mar;83(3):281-7. doi: 10.1111/j.1349-7006.1992.tb00101.x.